These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38360888)

  • 1. Exploring the therapeutic mechanisms and prognostic targets of Biochanin A in glioblastoma via integrated computational analysis and in vitro experiments.
    Ge W; Yuan G; Wang D; Dong L
    Sci Rep; 2024 Feb; 14(1):3783. PubMed ID: 38360888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
    Chen X; Pan Y; Yan M; Bao G; Sun X
    Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
    Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
    Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
    Yin X; Wu Q; Hao Z; Chen L
    Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
    Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z
    Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Gene Expression Data-Driven Identification of Molecular Signatures, Prognostic Biomarkers, and Drug Targets for Glioblastoma.
    Alom MW; Jibon MDK; Faruqe MO; Rahman MS; Akter F; Ali A; Rahman MM
    Biomed Res Int; 2024; 2024():6810200. PubMed ID: 39184354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of anti-gastric cancer effects and molecular mechanisms of resveratrol: From network pharmacology and bioinformatics to experimental validation.
    Ma YQ; Zhang M; Sun ZH; Tang HY; Wang Y; Liu JX; Zhang ZX; Wang C
    World J Gastrointest Oncol; 2024 Feb; 16(2):493-513. PubMed ID: 38425392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network pharmacology -based study on the mechanism of traditional Chinese medicine in the treatment of glioblastoma multiforme.
    Liang C; Zhang B; Li R; Guo S; Fan X
    BMC Complement Med Ther; 2023 Sep; 23(1):342. PubMed ID: 37759283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of lycorine in the treatment of glioblastoma based on network pharmacology and molecular docking.
    Su J; Huo M; Xu F; Ding L
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1551-1559. PubMed ID: 37668687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
    Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
    Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
    Dong C; Fan W; Fang S
    J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wang K; Wang Z; Wang Z; Xie X; Zang L; Wang L; Che F
    Front Oncol; 2022; 12():962970. PubMed ID: 36059675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology, molecular docking, combined with experimental verification to explore the role and mechanism of shizhifang decoction in the treatment of hyperuricemia.
    Wu Z; Wang C; Yang F; Zhou J; Zhang X; Xin J; Gao J
    Heliyon; 2024 Feb; 10(3):e24865. PubMed ID: 38322942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology-based screening of the active ingredients and mechanisms of evodiae fructus anti-glioblastoma multiforme.
    Wu G; Hao Q; Liu B; Zhou J; Fan C; Liu R
    Medicine (Baltimore); 2022 Sep; 101(39):e30853. PubMed ID: 36181021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
    Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
    Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of potential core genes for glioblastoma.
    Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy.
    Dong Q; Wang D; Li L; Wang J; Li Q; Duan L; Yin H; Wang X; Liu Y; Yuan G; Pan Y
    Mol Neurobiol; 2022 Feb; 59(2):1262-1272. PubMed ID: 34981417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.